Lelantos Holdings, Inc. Achieves OTC Level 2 Quotation and Improved Disclosure Service Approval
July 2nd, 2025 1:15 PM
By: Newsworthy Staff
Lelantos Holdings, Inc. (OTC PINK: LNTO) has qualified for OTC Level 2 quotations and been approved for the Improved Disclosure Service, marking significant steps in enhancing investor transparency and market visibility.
Lelantos Holdings, Inc. (OTC PINK: LNTO) has reached a significant milestone by qualifying for OTC Level 2 quotations on the OTC Markets platform, a development that enhances real-time trading visibility and market transparency for investors. This level of access provides detailed bid and ask data across all market makers, offering deeper insight into stock activity. Nathan Puente, CEO of Lelantos Holdings, highlighted this achievement as a pivotal step in the company's capital markets strategy.
In addition to gaining OTC Level 2 quotations, Lelantos Holdings has received approval to join OTC Markets' Improved Disclosure Service starting July 2025. Joshua Weaver, COO, stated that this move underscores the company's dedication to transparency, regulatory compliance, and fostering long-term trust with investors. These developments are expected to significantly benefit stakeholders by providing clearer insights into the company's operations and financial health.
For further details, the full press release can be viewed at https://ibn.fm/3lrgA.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
